Recruiting

Personalized Nutrition and Continuous Glucose Monitoring for Type 2 Diabetes

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Unblinded CGM/Nutrition Therapy

+ Blinded CGM/Nutrition Therapy

+ Unblinded CGM/No Nutrition Therapy

Behavioral
Who is being recruted

Diabetes Mellitus+3

+ Diabetes Mellitus, Type 2

+ Endocrine System Diseases

Over 18 Years
+10 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: July 2025
See protocol details

Summary

Principal SponsorUniversity of Minnesota
Study ContactAnne Bantle
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: July 14, 2025

Actual date on which the first participant was enrolled.

This study is focused on improving the health of people with type 2 diabetes by looking at how personalized nutrition plans can help manage their condition. The study uses a technology called continuous glucose monitoring (CGM) to tailor nutrition advice specifically for each participant. Type 2 diabetes often requires careful management of diet to keep blood sugar levels in check, and this study aims to see if using CGM can make nutrition therapy more effective compared to standard methods. Participants in the study will receive a personalized nutrition plan based on feedback from a continuous glucose monitor, which is a device that tracks blood sugar levels throughout the day. The study will compare this personalized approach to other standard nutrition interventions to evaluate which is more beneficial in controlling diabetes. Participants will likely have to follow specific dietary guidelines and may need to wear the CGM device regularly to collect data. The main goal is to assess how these personalized plans affect diabetes management, potentially leading to better health outcomes for people with type 2 diabetes.

Official TitlePersonalized Nutrition Using Continuous Glucose Monitoring to Improve Outcomes in Type 2 Diabetes Mellitus
NCT06784375
Principal SponsorUniversity of Minnesota
Study ContactAnne Bantle
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

72 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Diabetes MellitusDiabetes Mellitus, Type 2Endocrine System DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesGlucose Metabolism Disorders

Criteria

3 inclusion criteria required to participate
at least 18 years of age

previous diagnosis of T2DM

HbA1c of 6.8-8.5%

7 exclusion criteria prevent from participating
type 1 diabetes mellitus

treatment with insulin, sulfonylurea, or meglitinide

use of nondiabetic medications that affect blood glucose control (such as corticosteroids)

BMI <25 kg/m2 or <23 kg/m2 for participants who self-identify as Asian

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

4 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental

Group II

Experimental

Group III

Experimental

Group IV

Experimental

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

University of Minnesota

Minneapolis, United StatesOpen University of Minnesota in Google Maps
Recruiting
One Study Center
Personalized Nutrition and Continuous Glucose Monitoring for Type 2 Diabetes | PatLynk